Condition
Ablation of Atrial Fibrillation
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+14% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 1 (1)
Trial Status
Withdrawn1
Completed1
Active Not Recruiting1
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06706518Completed
Systematic Workflow for Pentaspline Pulsed-field Ablation Optimization
NCT07359872Phase 1Not Yet Recruiting
Relaxin Therapy for Atrial Fibrillation
NCT06355063Not ApplicableRecruiting
CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation
NCT06646887Not ApplicableActive Not Recruiting
Comparison of Different Electroporation Systems in the Ablation Treatment of Atrial Fibrillation
NCT01298986Early Phase 1WithdrawnPrimary
Atrial Fibrillation Ablation The Hybrid Approach Versus Traditional Management
Showing all 5 trials